The acetylcholinesterase reactivator HI-6 (1-[[[4-(aminocarbonyl)pyridinio]methoxylmethyl]-2-[(hydroxyimino)methyl]-pyridinium dichloride): a comparative study of HI-6 samples from various sources
Tóm tắt
A comparison of the chemical purity, toxicology and potency of HI-6 (1-[[[4-(aminocarbonyl)pyridinio]methoxy]methyl]-2-[(hydroxyimino)methyl]-pyridinium dichloride) obtained from various sources (Canada, Israel, Yugoslavia, The Netherlands, United Kingdom) was performed. There were no significant differences between HI-6 obtained from Israel, Yugoslavia, The Netherlands and Canada regarding their potency, when combined with atropine, as an antidote of organophosphate poisoning. HI-6 obtained from the United Kingdom was significantly more toxic and less potent than any of the other HI−6 samples. In addition, the results of this study showed that there was no significant difference between HI−6 prepared as a laboratory batch and HI−6 prepared commercially with regards to chemical purity, toxicology or potency.
Tài liệu tham khảo
Benschop HP, Konings CAG, Kossen P, Ligtenstein DP (1981) Determination of some pyridinium aldoxime compounds by means of ion-pair reversed phase HPLC; applications in biological material. J Chromatogr 225: 107–114
Binenfeld Z, Deljac V, Maksimović V, Rakin D (1978) HI−6 potencijalni antidot u trovanjima visokotoksicnim inhibitorima kolinesterazu. Zbornik VMA 15–17
Bošković B (1979) The influence of 2-/o-cresyl/-4H-1∶3∶2-benzodioxaphosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy. Arch Toxicol 42: 207–216
Bošković B, Kovačecić V, Jovanović D (1984) PAM-2 Cl, HI-6 and HGG-12 in soman and tabun poisoning. Fundam Appl Toxciol 4: S106-S115
Clement JG (1981) Toxicology and pharmacology of bis-pyridinium oximes. Insight into the mechanism of action vs soman poisoning in vivo. Fundam Appl Toxicol 1: 193–202
Clement JG (1982) Effect of fasting on the acute toxicity of HI-6 and its efficacy in soman poisoned mice. Fundam Appl Toxicol 2: 88–89
Clement JG (1983) Efficacy of mono- and bis-pyridinium oximes versus soman, sarin and tabun poisoning in mice. Fundam Appl Toxicol 3: 533–535
Clement JG, Lockwood PA (1982) HI-6, an oxime which is an effective antidote of soman poisoning: a structure-activity study. Toxicol Appl Pharmacol 64: 140–146
Finney DJ (1978) Probit analysis. Cambridge University Press, Cambridge, 3rd edition
Inns RH, Leadbeater L (1983) The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea pig. J Pharm Pharmacol 35: 427–433
Kepner LA, Wolthuis OL (1981) A comparison of the oximes HS-6 and HI-6 in the therapy of soman intoxication in rodents. Eur J Phrmacol 48: 377–382
Lundy PM, Tremblay KP (1979) Ganglion blocking properties of some bispyridinium soman antagonists. Eur J Pharmacol 60: 47–53
Maksimović M, Bosković B, Radović L, Deljac V, Binenfeld Z (1980). Antidotal effects of bispyridinium-2-monooxime carbonyl derivatives in intoxications with highly toxic organophosphorus compounds. Acta Pharm Jugosl 30: 151–160
Schoene K (1967) Darstellung und Untersuchung neuer Acetylcholinesterase Reaktivatoren. Thesis. University of Freiburg
Stahl E (1969) Thin layer chromatography. Springer-Verlag, Berlin
Waysbort D, Balderman D, Amitai G (1981) Carbon-13 NMR characterization of the bispyridinium oximes, toxogonin, HS-3, HS-6 and HI-6. Org Mag Resonance 16: 7–10